Monday’s stock market has experienced a variety of intra-day movements, with significant activity in both the mega-cap and large-cap categories. Stocks such as NVIDIA (NASDAQ:), Applovin (APP) and Boeing Co (NYSE:) have seen notable increases, while Cigna Corp (NYSE:) and Diamond Eagle Acquisition Corp (DKNG) have faced declines. Here’s an overview of some of the most impactful stock movers, spanning from mega-caps to small caps.
Mega-Cap Movers:
- NVIDIA (NVDA): +1.9%; sees continued momentum on AI gains
Large-Cap Stock Movers:
- Applovin (APP); BofA raises price target to $210; +8.24%
- Boeing Co (BA); Emirates SkyCargo to Expand Fleet, Capacity with Five More Boeing 777 Freighters; +4.14%
- Kenvue Inc (NYSE:); Starboard Value Builds Stake In Tylenol-Maker Kenvue – WSJ; +6.56%
- Ritchie Bros. Auctioneers (NYSE:); +6.18%
- Marvell (NASDAQ:) Technology Group Ltd (MRVL); +3.41%
- Cigna Corp (CI); falls on report it is in talks again to merge with Huana (HUM); -4.16%
- DraftKings (NASDAQ:); -4.11%
- Monolithic Power (NASDAQ:); -3.52%
Mid-Cap Stock Movers:
- Oklo (OKLO); sees continued momentum on big tech’s nuclear ambitions; +9.24%
- Construction Partners Inc (NASDAQ:); CPI announces acquisition of Lone Star Paving for $654 million; +12.22%
- Ikonics Corp (WULF); +10.4%
- Alkami Technology (ALKT); +5.94%
- Ibotta (IBTA); +5.94%
- Neumora Therapeutics (NMRA); -14.55%
- VF Corp (NYSE:); JP Morgan adds to negative catalyst watch; -6.76%
- Avidity Biosciences Inc (RNA); -7.64%
Small-Cap Stock Movers:
- Nano Nuclear Energy (NNE); sees continued momentum on big tech’s nuclear ambitions; +16.09%
- Viad Corp (NYSE:); Viad to sell GES unit for $535 million, to become Pursuit; +15.29%
- Ehang Holdings Ltd (NASDAQ:); +14.3%
- Audioeye, Inc (AEYE); +12.05%
- European Biotech Acquisition (OCS); Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees; +10.66%
- HPX (AMBI); +7.74%
- Alpha Teknova (TKNO); -7.0%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.